UncategorizedBeacon Therapeutics treats first patient in Phase 1/2 trial for X-linked retinitis pigmentosa – Longevity.Technology Empower Meds / December 17, 2025
UncategorizedAviceda reports Phase 2b SIGLEC results for AVD-104 in geographic atrophy – Longevity.Technology Empower Meds / December 16, 2025
Uncategorized7 habits longevity experts say will add life to your years Empower Meds / December 16, 2025
UncategorizedHundred Health launches integrated proactive care platform Empower Meds / December 16, 2025
UncategorizedAeovian lands $55m to advance pipeline focused on mTOR biology Empower Meds / December 16, 2025
UncategorizedSerina Therapeutics appoints Joshua Thomas as head of chemistry – Longevity.Technology Empower Meds / December 16, 2025
UncategorizedAB Science highlights masitinib clinical benefit in ALS subgroup analysis – Longevity.Technology Empower Meds / December 16, 2025
UncategorizedLilly weight loss drug exceeds targets in Phase III trial Empower Meds / December 16, 2025
